|
|
|
|
Philadelphia Biomedical Research Institute, King of Prussia, PA 19406
3To whom correspondence should be addressed. E-mail: stohnishi{at}aol.com.
ABSTRACT
The efficacy of S-allylcysteine (SAC) as a free radical
scavenger was studied using rat brain ischemia models. In a middle
cerebral artery occlusion model, preischemic administration of SAC had
the following effects: it improved motor performance and memory
impairment and reduced water content and the infarct size. In a
transient global ischemia model, the time course of free radical
(alkoxyl radical) formation as studied by electron paramagnetic
resonance (EPR) spectroscopy and
-phenyl-N-tert-butylnitrone (PBN) was
biphasic; the first peak occurred at 5 min and the second at 20 min
after reperfusion. Although SAC did not attenuate the first peak, it
did affect the second peak, which is related to lipid peroxidation. The
lipid peroxidation as estimated by thiobarbituric acid reactive
substances (TBARS) increased significantly at 20 min after reperfusion.
SAC decreased TBARS to the levels found without ischemia. These results
suggest that SAC could have beneficial effects in brain ischemia and
that the major protective mechanism may be the inhibition of free
radicalmediated lipid peroxidation.
KEY WORDS: S-allylcysteine brain ischemia motor performance memory impairment free radicals lipid peroxidation
This article has been cited by other articles:
![]() |
C. Cruz, R. Correa-Rotter, D. J. Sanchez-Gonzalez, R. Hernandez-Pando, P. D. Maldonado, C. M. Martinez-Martinez, O. N. Medina-Campos, E. Tapia, D. Aguilar, Y. I. Chirino, et al. Renoprotective and antihypertensive effects of S-allylcysteine in 5/6 nephrectomized rats Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1691 - F1698. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gilgun-Sherki, Z. Rosenbaum, E. Melamed, and D. Offen Antioxidant Therapy in Acute Central Nervous System Injury: Current State Pharmacol. Rev., June 1, 2002; 54(2): 271 - 284. [Abstract] [Full Text] [PDF] |
||||